Literature DB >> 10773199

Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine.

M Werme1, A Ringholm, L Olson, S Brené.   

Abstract

Disturbances of retinoid activated transcription mechanisms have recently been implicated as risk factors for schizophrenia. In this study we have compared the regulation of mRNAs for the nuclear orphan receptor NGFI-B, which forms a functional heterodimer with the retinoid x receptor and the related orphan nuclear receptor Nor1 with c-fos mRNA after acute and chronic treatments with haloperidol and clozapine. The antipsychotic drugs haloperidol and clozapine have different clinical profiles. Haloperidol is a typical neuroleptic giving extrapyramidal side effects (EPS), whereas the atypical compound clozapine does not. Acute haloperidol treatment increased NGFI-B, Nor1 and c-fos mRNAs in nucleus accumbens shell and core as well as medial and lateral caudate putamen. In contrast, clozapine lead to an increase of NGFI-B, Nor1 and c-fos only in the accumbens shell. No haloperidol or clozapine effect on these mRNAs was detected in cingulate, sensory or motor cortex. Chronic haloperidol lead to an increase of NGFI-B mRNA in the accumbens core. Acutely, it is possible that the increased levels of NGFI-B, Nor1 and c-fos mRNA levels in striatum and accumbens might indicate a neural activation which possibly can be used when screening for drugs that do not produce EPS. Also, the increased levels of NGFI-B, which is an important component in retinoid signaling, both after acute and chronic treatments of haloperidol suggests altered sensitivity to retinoids which could be an important component for the beneficial antipsychotic effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773199     DOI: 10.1016/s0006-8993(00)02109-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

1.  Repeated cocaine self-administration causes multiple changes in rat frontal cortex gene expression.

Authors:  Willard M Freeman; Karen Brebner; Kruti M Patel; Wendy J Lynch; David C S Roberts; Kent E Vrana
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs.

Authors:  B E H Sumner; L A Cruise; D A Slattery; D R Hill; M Shahid; B Henry
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

Review 3.  Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation.

Authors:  Daniel Lévesque; Claude Rouillard
Journal:  Trends Neurosci       Date:  2006-11-28       Impact factor: 13.837

Review 4.  The role of NR4A transcription factors in memory formation.

Authors:  Josh D Hawk; Ted Abel
Journal:  Brain Res Bull       Date:  2011-02-18       Impact factor: 4.077

5.  Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover.

Authors:  François Gilbert; Marc Morissette; Michel St-Hilaire; Brigitte Paquet; Claude Rouillard; Thérèse Di Paolo; Daniel Lévesque
Journal:  Biol Psychiatry       Date:  2006-08-07       Impact factor: 13.382

6.  Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain.

Authors:  T L Schochet; A E Kelley; C F Landry
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

7.  Repeated immobilization stress increases nur77 expression in the bed nucleus of the stria terminalis.

Authors:  Danae Campos-Melo; Gabriel Quiroz; Verónica Noches; Katia Gysling; María Inés Forray; María Estela Andrés
Journal:  Neurotox Res       Date:  2011-03-26       Impact factor: 3.911

Review 8.  The aetiology of idiopathic Parkinson's disease.

Authors:  D B Ramsden; R B Parsons; S L Ho; R H Waring
Journal:  Mol Pathol       Date:  2001-12

Review 9.  Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.

Authors:  Yael Chertkow; Orly Weinreb; Moussa B H Youdim; Henry Silver
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

10.  Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia.

Authors:  Jan Struyf; Seth Dobrin; David Page
Journal:  BMC Genomics       Date:  2008-11-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.